Adline Chem Lab Ltd
Fundamental Score
Adline Chem Lab Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of ADLINE across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Robust Profit Growth (22.22%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Weak Interest Coverage (0.08x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-0.35 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (29.61%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Adline Chem Lab Ltd
About ADLINE
Business Overview
Adline Chem Lab Limited markets pharmaceutical products in India and internationally. It also offers anti-infectives, gastroentology, haemostatic, padeatric, and bone health pharmaceutical related products. In addition, it provides hepatocare, pain and inflammation, pregnancy and reproductive care, respiratory care, and multi-vitamins in tablet, capsule, liquid orals, and injection forms. Further, the company offers veterinary products and educational supplements. The company was formerly known as Kamron Laboratories Limited and changed its name to Adline Chem Lab Limited in October 2021. Adline Chem Lab Limited was incorporated in 1988 and is based in Ahmedabad, India.
Company Details
Key Leadership
Latest News
ADLINE Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Adline Chem Lab Ltd (ADLINE)?
As of 19 Jan 2026, 10:12 am IST, Adline Chem Lab Ltd (ADLINE) is currently trading at ₹11.73. The stock has a market capitalization of ₹4.91 (Cr).
Is ADLINE share price Overvalued or Undervalued?
ADLINE is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Adline Chem Lab Ltd share price?
Key factors influencing ADLINE's price include its quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Adline Chem Lab Ltd a good stock for long-term investment?
Adline Chem Lab Ltd shows a 5-year Profit Growth of 14.49% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing.
How does Adline Chem Lab Ltd compare with its industry peers?
Adline Chem Lab Ltd competes with major peers in the Pharmaceuticals. Investors should compare ADLINE's P/E of 0.00x and ROE of N/A% against the industry averages to determine its competitive standing.
What is the P/E ratio of ADLINE and what does it mean?
ADLINE has a P/E ratio of N/Ax compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is ADLINE performing according to Bull Run's analysis?
ADLINE has a Bull Run fundamental score of 14.1/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does ADLINE belong to?
ADLINE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Adline Chem Lab Ltd.
What is Return on Equity (ROE) and why is it important for ADLINE?
ADLINE has an ROE of N/A%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Adline Chem Lab Ltd generates profits from shareholders' equity.
How is ADLINE's debt-to-equity ratio and what does it indicate?
ADLINE has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is ADLINE's dividend yield and is it a good dividend stock?
ADLINE offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has ADLINE grown over the past 5 years?
ADLINE has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 14.49%, and EPS Growth 14.49%.
What is the promoter holding in ADLINE and why does it matter?
Promoters hold 29.61% of ADLINE shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is ADLINE's market capitalization category?
ADLINE has a market capitalization of ₹5 crores, placing it in the Small-cap category.
How volatile is ADLINE stock?
ADLINE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for ADLINE?
ADLINE has a 52-week high of ₹N/A and low of ₹N/A.
What is ADLINE's operating profit margin trend?
ADLINE has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is ADLINE's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of N/A% and YoY Profit Growth of 22.22%.
What is the institutional holding pattern in ADLINE?
ADLINE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.